Evidence map›Paper›PMID 33793556›Full record

ArticlePloS one2021

Seroprevalence of hospital staff in a province with zero COVID-19 cases.

Tanawin Nopsopon, Krit Pongpirul, Korn Chotirosniramit, Wutichai Jakaew, Chuenkhwan Kaewwijit, Sawan Kanchana, Narin Hiransuthikul

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Monitoring the COVID-19 immune landscape in Japan.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  4. Article
  5. [Reply to "Effectiveness of mRNA Covid-19 vaccine in healthcare workers"].Enfermedades infecciosas y microbiologia clinica · 2022
    Article
  6. [Reply to "Effectiveness of mRNA Covid-19 vaccine in healthcare workers"].Enfermedades infecciosas y microbiologia clinica (English ed.) · 2022
    Article
  7. Effectiveness of mRNA Covid-19 vaccine in healthcare workers.Enfermedades infecciosas y microbiologia clinica · 2022
    Article
  8. Article
  9. Effectiveness of mRNA Covid-19 vaccine in healthcare workers.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2022
    Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Did Laos really control the transmission of SARS-CoV-2 in 2020?The Lancet regional health. Western Pacific · 2021
    Article
  18. Low seroprevalence of COVID-19 in Lao PDR, late 2020.The Lancet regional health. Western Pacific · 2021
    Article
  19. Tracking COVID-19 with wastewater to understand asymptomatic transmission.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tanawin NopsoponDepartment of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0003-0428-973X
Krit PongpirulDepartment of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0003-3818-9761
Korn ChotirosniramitDepartment of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Wutichai JakaewRanong Hospital, Ranong, Thailand.
Chuenkhwan KaewwijitRanong Hospital, Ranong, Thailand.
Sawan KanchanaRanong Hospital, Ranong, Thailand.
Narin HiransuthikulDepartment of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0002-1517-7445
Chulalongkorn University · THJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 seroprevalence data, particularly in less developed countries with a relatively low incidence, has been scant. We aimed to explore the seroprevalence of hospital staff in the area with zero confirmed COVID-19 case to shed light on the situation of COVID-19 infection in zero or low infection rate countries where mass screening was not readily available.

methodsA locally developed rapid immunoglobulin M (IgM)/immunoglobulin G (IgG) test kit was used for hospital staff screening of Ranong hospital which is located in a province with zero COVID-19 prevalence in Thailand from 17th April to 17th May 2020. All staff was tested, 100 of which were randomly invited to have a repeating antibody test in one month. (Thai Clinical Trials Registry: TCTR20200426002).

resultsOf 844 hospital staff, 82 were tested twice one month apart (response rate for repeating antibody test 82%). Overall, 0.8% of the participants (7 of 844) had positive IgM, none had positive IgG. Female staff had 1.0% positive IgM (95% CI: 0.5-2.1%) while male had 0.5% positive IgM (95% CI: 0.1-2.6%). No participants with a history of travel to the high-risk area or close contact with PCR-confirmed COVID-19 case developed SARS-CoV-2 antibodies. Among 844 staff, 811 had no symptoms and six of them developed IgM seropositive (0.7%) while 33 had minor symptoms and only one of them developed IgM seropositive (3.0%). No association between SARS-CoV-2 IgM status and gender, history of travel to a high-risk area, close contact with PCR-confirmed or suspected COVID-19 case, presence of symptoms within 14 days, or previous PCR status was found. None of the hospital staff developed SARS-CoV-2 IgG.

conclusionsCOVID-19 antibody test could detect a considerable number of hospital staff who could be potential silent spreaders in a province with zero COVID-19 cases. Accurate antibody testing is a valuable screening tool, particularly in asymptomatic healthcare workers. Trial registration: This study was approved by the Institutional Review Board of Chulalongkorn University (IRB No.236/63) and the Institutional Review Board of Ranong Hospital. (Thai Clinical Trials Registry: TCTR20200426002).

Indexed as

AdultAntibodies, ViralCOVID-19FemaleHumansImmunoglobulin GImmunoglobulin MMaleMiddle AgedPersonnel, HospitalSeroepidemiologic StudiesThailandAntibodies, ViralImmunoglobulin GImmunoglobulin M

Identifiers

PMID33793556
PMCPMC8016267
OpenAlexW3143509719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.